Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy
Trial ID or NCT#
NCT00490490
Status
NOT RECRUITING
Purpose
The purpose of the study is to assess the response rate of patients with relapsed or refractory low-grade or transformed low-grade, CD20-positive, B-cell non-Hodgkin's lymphoma to Iodine-131 (I-131) tositumomab (Bexxar) therapy plus local palliative radiation therapy (XRT).
Official Title
Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
Eligibility Criteria
Ages Eligible for Study: Older than 19 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Susan Knox
Michael L. Goris
Contact us to find out if this trial is right for you.
Contact
Lucy Schoen
6507251718
View on ClinicalTrials.gov
